Highlights and Quick Summary
- EPS Growth (basic) for the quarter ending March 31, 2023 was 0.0% (a -100.0% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (basic) decreased by -100.0%
- Annual EPS Growth (basic) for 2022 was 129.79% (a 140.71% increase from previous year)
- Annual EPS Growth (basic) for 2021 was 53.92% (a 5.31% increase from previous year)
- Annual EPS Growth (basic) for 2020 was 51.2% (a 9.35% increase from previous year)
- Twelve month EPS Growth (basic) ending March 31, 2023 was 129.17% (a -0.48% decrease compared to previous quarter)
- Twelve month trailing EPS Growth (basic) increased by 496.08% year-over-year
Trailing EPS Growth (basic) for the last four month:
31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
---|---|---|---|
129.17% | 129.79% | 121.05% | 21.67% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (basic) of Precigen, Inc.
Most recent EPS Growth (basic)of PGEN including historical data for past 10 years.Interactive Chart of EPS Growth (basic) of Precigen, Inc.
Precigen, Inc. EPS Growth (basic) for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | 0.0% | – | – | – | – |
2022 | 15.38% | 393.33% | 10.0% | -11.11% | 129.79% |
2021 | 43.48% | 16.67% | 61.54% | 74.29% | 53.92% |
2020 | 78.9% | 48.57% | -4.0% | 12.5% | 51.2% |
2019 | 57.92% | 20.45% | 50.98% | -21.21% | 46.82% |
2018 | -1026.09% | -33.33% | -218.75% | -26.92% | -301.02% |
2017 | 37.84% | -37.5% | 61.9% | 52.73% | 37.97% |
2016 | -32.14% | 29.41% | -13.51% | -311.54% | -107.89% |
2015 | -247.37% | 35.85% | 30.19% | 550.0% | 8.43% |
2014 | 246.15% | -453.33% | -211.76% | 108.33% | 40.71% |
2013 | -168.42% | 128.3% | 67.92% | -1300.0% | -19.66% |
2012 | – | – | – | – | 16.43% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology